Copyright 2024.
All rights reserved.
Terms Of Use | Privacy
000
people watching now..
Scientific References:
1. Chen J., Zhang D., Yan W., Yang D., Shen B. Translational Bioinformatics for Diagnostic and Prognostic Prediction of Prostate Cancer in the Next-Generation Sequencing Era. BioMed Res. Int. 2013;2013:901578. doi: 10.1155/2013/901578. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
2. Hjelmborg J.B., Scheike T., Holst K., Skytthe A., Penney K.L., Graff R.E., Pukkala E., Christensen K., Adami H.-O., Holm N.V., et al. The Heritability of Prostate Cancer in the Nordic Twin Study of Cancer. Cancer Epidemiol. Biomark. Prev. 2014;23:2303–2310. doi: 10.1158/1055-9965.EPI-13-0568. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
3. Termini D., Hartogh D.J.D., Jaglanian A., Tsiani E. Curcumin against Prostate Cancer: Current Evidence. Biomolecules. 2020;10:1536. doi: 10.3390/biom10111536. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
4. Wen S., Chang H.-C., Tian J., Shang Z., Niu Y., Chang C. Stromal Androgen Receptor Roles in the Development of Normal Prostate, Benign Prostate Hyperplasia, and Prostate Cancer. Am. J. Pathol. 2015;185:293–301. doi: 10.1016/j.ajpath.2014.10.012. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
5. Cittadini A., Isidori A.M., Salzano A. Testosterone therapy and cardiovascular diseases. Cardiovasc. Res. 2021;118:2039–2057. doi: 10.1093/cvr/cvab241. [PubMed] [CrossRef] [Google Scholar]
6. Bluemn E.G., Nelson P.S. The androgen/androgen receptor axis in prostate cancer. Curr. Opin. Oncol. 2012;24:251–257. doi: 10.1097/CCO.0b013e32835105b3. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
7. Ziaran S., Novakova Z.V., Böhmer D., Danišovič L. Biomarkers for determination prostate cancer: Implication for diagnosis and prognosis. Neoplasma. 2015;62:683–691. doi: 10.4149/neo_2015_082. [PubMed] [CrossRef] [Google Scholar]
8. Takayama K.-I. Splicing Factors Have an Essential Role in Prostate Cancer Progression and Androgen Receptor Signaling. Biomolecules. 2019;9:131. doi: 10.3390/biom9040131. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
9. Bach C., Pisipati S., Daneshwar D., Wright M., Rowe E., Gillatt D., Persad R., Koupparis A. The status of surgery in the management of high-risk prostate cancer. Nat. Rev. Urol. 2014;11:342–351. doi: 10.1038/nrurol.2014.100. [PubMed] [CrossRef] [Google Scholar]
10. Ziegler A., Koch A., Krockenberger K., Großhennig A. Personalized medicine using DNA biomarkers: A review. Qual. Life Res. 2012;131:1627–1638. doi: 10.1007/s00439-012-1188-9. [PMC free article] [PubMed] [CrossRef] [Google Scholar]